← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2005Last known activity
Nov 1, 2020
Defunct as of Dec 31, 2014
Timeline
2000s
- Jun 1, 2002
Orexigen Therapeutics, Inc— Founded
2010s
- Dec 31, 2014
Orexigen Therapeutics, Inc— Defunct
Drugs by trial phase (7 distinct, 19 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (21)
- NCT04399395CollaboratorPhase 4Nov 1, 2020
- NCT02745912Lead sponsorPhase 1Apr 1, 2016
- NCT02735603Lead sponsorPhase 1Apr 1, 2016
- NCT02638129Lead sponsorPhase 4Jan 1, 2016
- NCT02259179Study directorPhase 1Sep 1, 2014
- NCT02259179Lead sponsorPhase 1Sep 1, 2014
- NCT01764386Study directorPhase 3Feb 1, 2013
- NCT01764386Lead sponsorPhase 3Feb 1, 2013
- NCT01601704Lead sponsorPhase 3Jun 1, 2012
- NCT00734435Lead sponsorPhase 2Sep 1, 2008
- NCT00758966Lead sponsorPhase 2Sep 1, 2008
- NCT00711477Lead sponsorPhase 2Sep 1, 2008
- NCT00709371Lead sponsorPhase 2Jul 1, 2008
- NCT00624858Lead sponsorPhase 2Jan 1, 2008
- NCT00567255Lead sponsorPhase 3Dec 1, 2007
Details
- Founded
- La Jolla, CA, US Jun 1, 2002
- Last known activity
- Nov 1, 2020